Mary Ann Savaria, APRN
Adult Health · Danielson, CTNPI 1831443001
Payments from drug & device makers
Across 47 payments — averaging $63.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- Boehringer Ingelheim$187
- E.r. Squibb & Sons, L.L.C.$146
- Impulse Dynamics (USA) Inc.$54
- Merck$53
- Alnylam Pharmaceuticals Inc.$46
- plus $87 from 3 others
What the payments were for
- Travel & lodging$1,85362%
- Food & beverage$1,10737%
- Education$221%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 22 | $2,408 |
| Boehringer Ingelheim | 2 | $187 |
| E.r. Squibb & Sons, L.L.C. | 8 | $146 |
| Impulse Dynamics (USA) Inc. | 7 | $54 |
| Merck | 2 | $53 |
| Alnylam Pharmaceuticals Inc. | 2 | $46 |
| Novo Nordisk | 2 | $46 |
| AstraZeneca | 1 | $26 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CARDIOMEMS$1,758
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$358
- JARDIANCE$117
How this compares
$2,982 in reported general payments places this provider in the 80th percentile of 418 adult health providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VyndamaxTafamidis | 188 | $6,264,361 |
| JardianceEmpagliflozin | 498 | $649,130 |
| EntrestoSacubitril/Valsartan | 388 | $577,215 |
| FarxigaDapagliflozin Propanediol | 209 | $276,886 |
| VeltassaPatiromer Calcium Sorbitex | 22 | $45,947 |
| Eplerenone | 132 | $15,161 |
| Torsemide | 382 | $12,104 |
| Spironolactone | 588 | $5,630 |
| Midodrine Hcl | 59 | $4,708 |
| Metoprolol Succinate | 164 | $3,234 |
| Carvedilol | 297 | $2,922 |
| Bumetanide | 19 | $1,169 |
| Acetazolamide | 21 | $1,005 |
| Digoxin | 41 | $939 |
| Hydralazine Hcl | 43 | $824 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $187 | $649,130498 claims |
| AstraZenecaFarxiga | $26 | $276,886209 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 418 adult health providers in Connecticut.
Other adult health in Danielson
- Mary D AmicoDanielson$11K
- Leah EhleManchester$418K
- Laura MulkaWethersfield$306K
- Gretchen MichaelsonSouth Windsor$169K
- Kimberly RyanWethersfield$74K
- Kathryn JackMeriden$67K
- Lynn RapsilberTorrington$52K
- Genice NelsonFarmington$36K
- Andrea LauterNew London$32K
- Megan CarlucciManchester$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.